behavior than the intestinal type. 7 The anatomical location of gastric cancer also influences prognosis; a recent study showed that gastric cancers in the cardia or proximal-third gastric cancer are associated with a worse prognosis than middle-or distalthird gastric cancers. 8 However, at present, these histopathological, anatomic, and epidemiological distinctions are not taken into account in the clinical management of gastric cancer.
Shah et al. 9 recently hypothesized that the Lauren classification system should be modified to include both the Lauren pathological classification and the anatomical location of gastric cancer, thus yielding at least three entirely distinct types termed the proximal non-diffuse type (PND), Lauren's diffuse type (D), and distal non-diffuse type (DND). Their molecular biological analyses then showed that there were marked differences between these three types in terms of mRNA expression profiles.
In the present retrospective cohort study, we aimed to evaluate the clinical significance of this modified Lauren classification (MLC) system. The specific aims of our study were to compare the clinicopathological characteristics of Korean patients with resectable gastric adenocarcinoma who were divided according to the MLC system and to assess the prognostic value of MLC in gastric adenocarcinoma.
Materials and Methods 
Modified Lauren classification
PND tumors were those whose bulk (＞80%) was located in the gastric cardia. These tumors extended up to the gastroesophageal junction and a small portion of the distal esophagus. They had Lauren intestinal type histopathology. The D tumors could be located anywhere in the stomach but had Lauren diffuse and mixed type histopathology. DND tumors were those whose bulk was usually in the distal stomach, although they could extend up to the mid body of the stomach or down to the pylorus. They had Lauren intestinal type histopathology. The patients were classified according to the tumor location and Lauren classification based on the final pathological report.
Statistical analysis
All statistical analyses were performed by PASW ver. 18.0 (IBM Co., Armonk, NY, USA) software. P-values ＜0.05 were considered to be statistically significant. The overall survival period was defined as the time from the diagnosis of cancer to death or the last out-patient department visit day. The disease free survival period was defined as the time from diagnosis of cancer to the identified date of recurrence. The MLC patient groups were compared in terms of clinical characteristics by chisquared test. The survival curves of the three groups were generated by Kaplan-Meier analysis and were compared by using the log-rank test. Univariate analyses were performed by KaplanMeier analysis with log-rank test, and multivariate analyses were performed with the variables that were significant on univariate analysis and by using the Cox proportional hazard model.
Results

Patients
In total, 677 patients were eligible to enroll in our study. Values are presented as number only, mean±standard deviation, or number (%). PND = proximal non-diffuse modified Lauren type; D = diffuse modified Lauren type; DND = distal non-diffuse modified Lauren type; M = male; F = female; BMI = body mass index; EBL = estimated blood loss. 
Pathological outcomes
In the PND, D, and DND groups, the mean tumor size was (Table 5) . 
Discussion
The present study on the clinical relevance of the MLC sys- Shah et al. 9 proposed that gastric adenocarcinoma is a heterogeneous disease with subtypes that differ in terms of epidemiology and histopathology. This is supported by other studies that
showed that the anatomical location of gastric cancer has clinical relevance: gastric cardia or proximal-third gastric adenocarcinoma is associated with a worse prognosis than middle-or distal-third gastric cancer. [18] [19] [20] As a result, Shah et al. 9 hypothesized that a modification of the Lauren classification that takes into account the anatomical location of the tumor may be even more useful than the existing Lauren classification. The proposed MLC system allows gastric adenocarcinoma to be classified into three types, namely, PND, D, and DND. 21 Shah et al. 9 then showed that these types differed significantly in their gene expression profiles. Our study showed that these three types Closer analysis of the 5-year overall survival rates showed that the PND group had a poor prognosis compared to the DND group, but a similar 5-year overall survival rate compared to the D group. However, the PND group did not differ from the DND group in terms of pT and pN stages. This is consistent with the findings of Shah et al. 9 However, in our multivariate analysis, age and pT and pN stages, but not MLC, were associated with 5-year overall survival. Further studies assessing the clinical relevance of MLC in gastric cancer are warranted.
The implementation of nationwide screening programs with endoscopy in Japan and Korea has led to a recent surge in the detection of EGC. As a result, EGC currently accounts for approximately 50% of all curative gastrectomies that are performed for gastric cancer in Korea. [22] [23] [24] This study has some limitations. First, it is a retrospective study from a single center. However, the fact that it is a single center study has some advantages; our institute follows the Japanese Gastric Cancer treatment guidelines, 10 which means that all patients were treated with the same surgical method. Moreover, all procedures were performed by the same two experienced surgeons. This may have reduced the impact of surgeon experience and surgical method on survival. Second, the sample size of the PND group was rather small, especially in the EGC subgroup analysis. This reflects the fact that EGC has a good prognosis and thus patients with such early stage disease are less willing than patients with advanced gastric cancer to continue having regular checkups after curative resection. As a result, many patients with EGC are lost to follow-up. Further studies with multiple centers that enroll more patients are needed to confirm our results.
In conclusion, DND type gastric cancer was associated with a favorable 5-year overall survival rate compared to PND and D type disease. MLC was an independent prognostic factor in multivariate analysis of patients with EGC, although this was not observed in the multivariate analysis of the entire cohort.
Further studies on the clinical relevance of MLC in EGC are needed.
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